Information on patents, trademarks, and clinical for new drug material…
페이지 정보
작성자 ㈜MST 조회2,022 View 작성일 25-12-01 11:24본문
The Company is MST(KOREA), CEO/W. S. Moon, www.BioCleanAct.com , Brand name: BioMuCol, BioCleanAct, 柏傲特)
Our company succeeds in cultivating it with the advanced smart farm method and manufactures the extraction process -> the advanced fermentation method through the process Dioscorea bulbifera, a medicinal plant (herbal medicine), and new materials based on natural products,
Domestic patent acquisition, international patent (PCT), trademark acquisition, and human clinical (efficacy, safety) tests for exosomes (extracellular vesicles) manufactured using this are in progress.
**Notice:**:
Our company practices ESG management from the cultivation of raw materials (agriculture) to the final production of all our products. We are committed to carbon neutrality by utilizing eco-friendly smart farm advanced agricultural technology throughout farming, extraction, fermentation, and product manufacturing. Additionally, we cultivate raw materials using environmentally friendly agricultural methods.

International Patent Application Number: PCT/KR2025/099275


International Patent (PCT) Investigation Report

Clinical trial information.
Brand name : BioCleanAct (BioMuCol)
Product code no. : MSK-NE688



**Authorized report for "Mucin" content test.**

1) Function for preventing and improving cognitive impairment (dementia prevention and treatment). Trademark registration–December 01, 2025.
2) Natural skin regeneration function. Trademark registration.–December 01, 2025.



